Surgical Science Sweden AB (publ) (SUSRF)

Market Cap	137.21M -83.1%
Revenue (ttm)	103.48M +13.4%
Net Income	7.41M -63.9%
EPS	0.15 -63.9%
Shares Out	n/a
PE Ratio	18.52
Forward PE	10.44
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	5,232
Open	3.410
Previous Close	3.630
Day's Range	3.410 - 3.410
52-Week Range	3.160 - 16.330
Beta	0.52
RSI	19.42
Earnings Date	Feb 19, 2026

About SUSRF

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy tra...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1997
• Employees: 328
• Stock Exchange: OTCMKTS
• Ticker Symbol: SUSRF

Financial Performance

In 2024, SUSRF's revenue was 884.09 million, an increase of 0.14% compared to the previous year's 882.85 million. Earnings were 131.65 million, a decrease of -43.73%.

Financial numbers in SEK